GNMK News and Press, GenMark Diagnostics Inc. From 12/11/19

AdaptHealth (NASDAQ: AHCO ) initiated with Outperform rating and $13 (30% upside) price target at SVB Leerink. More news on: AdaptHealth Corp., CryoLife, Inc., Acadia Healthcare Company, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Image source: The Motley Fool. GenMark Diagnostics Inc   (NASDAQ: GNMK) Q3 2019 Earnings Call Nov 6, 2019 , 4:30 p.m. ET Operator Continue reading

GenMark Diagnostics, Inc. (GNMK) Q3 2019 Earnings Conference Call November 6, 2019 4:30 PM ET Company Participants Leigh Salvo – Investor Relations Hany Massarany – President and Chief Executive Officer Scott Mendel – Chief Operating Officer Johnny Ek ...

GenMark Diagnostics (NASDAQ: GNMK ): Q3 GAAP EPS of -$0.20 misses by $0.01 . Revenue of $20.9M (+32.3% Y/Y) beats by $0.39M . Press Release More news on: GenMark Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news,

CARLSBAD, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended September 30, 2019. Highlights Recognized total reve...

CARLSBAD, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Wednesday, November 6, 2019. Management will hold a conference call to review the company's fin...

Thinly traded GenMark Diagnostics ( GNMK +14.1% ) is up 15% higher volume, albeit on turnover of only 361K shares, on the heels of its Q2 report released after the close yesterday. More news on: GenMark Diagnostics, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on ...

GenMark (NASDAQ: GNMK ) has filed to offer up to $35M in common stock. More news on: GenMark Diagnostics, Inc., Healthcare stocks news, Read more ...

GenMark Diagnostics (NASDAQ: GNMK ): Q2 GAAP EPS of -$0.23 misses by $0.03 . More news on: GenMark Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

CARLSBAD, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended June 30, 2019. Highlights Recognized total revenue o...